Company Overview of ScarX Therapeutics
ScarX Therapeutics, a pre-clinical stage biotechnology company, engages in the development of a therapeutic as the patient-administered prescription medication for the prophylaxis of dermal scarring in post-surgical wound closures. It develops MI-001 as an anti-scarring agent. The company is based in Toronto, Canada.
Key Executives for ScarX Therapeutics
Similar Private Companies By Industry
|Precision Nanosystems, Inc.||Americas|
|Fast Genetics Inc.||Americas|
|Glyko Biomedical Ltd.||Americas|
|Okanagan Specialty Fruits Inc.||Americas|
|ImTec Therapeutics Ltd||Americas|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact ScarX Therapeutics, please visit www.scarxtherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.